The largest database of trusted experimental protocols

2 protocols using stat5

1

Western Blot Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in cold lysis buffer containing 5 mM NA3VO4, protease inhibitors (Complete, Roche, Bazel, Switzerland) and PhosSTOP (Roche). The proteins were separated on NuPAGE NOVEX Bis-Tris 4 to 12% gels (Invitrogen, Carlsbad, CA, USA). Western blot analysis was performed using antibodies against JAK3 (Cell Signaling, Danvers, MA, USA 3775), phospho-STAT5 (Y694) (Cell Signaling 9359); STAT5 (Invitrogen 335900), phospho-RanBP3 (Cell Signaling 9380); phospho-4E-BP1 (Cell Signaling 2855); pERK1/2 (Cell Signaling 9101), ERK1 (Santa Cruz, Dallas, TX, USA, Sc-93), pMEK1/2 (Cell Signaling 9154), MEK1/2 (Cell Signaling 9126) and β-actin (Sigma-Aldrich A1978); secondary antibodies were conjugated with horseradish peroxidase (GE Healthcare, Chicago, IL, USA). Bands were visualized using a cooled charge-coupled device camera (ImageQuant LAS-4000; GE Healthcare).
+ Open protocol
+ Expand
2

Western Blot Analysis of JAK-STAT Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was obtained from cells or tissues using a lysis buffer (Cell Signaling Technology, California, USA), and protein levels were quantified using the BCA kit (Shanghai Ze Ye Biotechnology Co., Ltd, Shanghai, China). Subsequently, approximately 30 μg of protein was loaded and separated by 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis. The proteins were then transferred to a polyvinylidene fluoride membrane (Millipore, Massachusetts, USA), followed by incubation with 5% bovine serum albumin and incubation with the primary antibodies against JAK1 (1:800, Invitrogen, Massachusetts, USA), p-JAK1 (1:800, Invitrogen, Massachusetts, USA), JAK2 (1:800, Invitrogen, Massachusetts, USA), p-JAK1 (1:800, Invitrogen, Massachusetts, USA), STAT3 (1:800, Invitrogen, Massachusetts, USA), p-STAT3 (1:800, Invitrogen, Massachusetts, USA), STAT5 (1:800, Invitrogen, Massachusetts, USA), p-STAT5 (1:800, Invitrogen, Massachusetts, USA), and GAPDH (1:800, Invitrogen, Massachusetts, USA). Subsequently, the membranes were incubated with a secondary antibody (1:2000; Invitrogen, Massachusetts, USA). Finally, enhanced chemiluminescence (Invitrogen, Massachusetts, USA) was used for the visualization of bands, followed by quantification using the ImageJ software (National Institutes of Health, USA) [19 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!